Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958–2009

This is the third analysis of solid cancer incidence among the Life Span Study (LSS) cohort of atomic bomb survivors in Hiroshima and Nagasaki, adding eleven years of follow-up data since the previously reported analysis. For this analysis, several changes and improvements were implemented, including updated dose estimates (DS02R1) and adjustment for smoking. Here, we focus on all solid cancers in aggregate. The eligible cohort included 105,444 subjects who were alive and had no known history of cancer at the start of follow-up. A total of 80,205 subjects had individual dose estimates and 25,239 were not in either city at the time of the bombings. The follow-up period was 1958–2009, providing 3,079,484 person-years of follow-up. Cases were identified by linkage with population-based Hiroshima and Nagasaki Cancer Registries. Poisson regression methods were used to elucidate the nature of the radiation-associated risks per Gy of weighted absorbed colon dose using both excess relative risk (ERR) and excess absolute risk (EAR) models adjusted for smoking. Risk estimates were reported for a person exposed at age 30 years with attained age of 70 years. In this study, 22,538 incident first primary solid cancer cases were identified, of which 992 were associated with radiation exposure. There were 5,918 cases (26%) that occurred in the 11 years (1999–2009) since the previously reported study. For females, the dose response was consistent with linearity with an estimated ERR of 0.64 per Gy (95% CI: 0.52 to 0.77). For males, significant upward curvature over the full dose range as well as restricted dose ranges was observed and therefore, a linear-quadratic model was used, which resulted in an ERR of 0.20 (95% CI: 0.12 to 0.28) at 1 Gy and an ERR of 0.010 (95% CI: −0.0003 to 0.021) at 0.1 Gy. The shape of the ERR dose response was significantly different among males and females (P = 0.02). While there was a significant decrease in the ERR with increasing attained age, this decrease was more rapid in males compared to females. The lowest dose range that showed a statistically significant dose response using the sex-averaged, linear ERR model was 0–100 mGy (P = 0.038). In conclusion, this analysis demonstrates that solid cancer risks remain elevated more than 60 years after exposure. Sex-averaged upward curvature was observed in the dose response independent of adjustment for smoking. Findings from the current analysis regarding the dose-response shape were not fully consistent with those previously reported, raising unresolved questions. At this time, uncertainties in the shape of the dose response preclude definitive conclusions to confidently guide radiation protection policies. Upcoming results from a series of analyses focusing on the radiation risks for specific organs or organ families, as well as continued follow-up are needed to fully understand the nature of radiation-related cancer risk and its public health significance. Data and analysis scripts are available for download at: http://www.rerf.or.jp.

[1]  J. Harrison,et al.  Solid cancer incidence other than lung, liver and bone in Mayak workers: 1948–2004 , 2013, British Journal of Cancer.

[2]  David B Richardson,et al.  Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS) , 2015, BMJ : British Medical Journal.

[3]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases , 2012, Radiation research.

[4]  Sachiyo Funamoto,et al.  Dose Estimation for Atomic Bomb Survivor Studies: Its Evolution and Present Status , 2006, Radiation research.

[5]  D. Pierce,et al.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses. , 1989, Radiation research.

[6]  W. Cleveland,et al.  Locally Weighted Regression: An Approach to Regression Analysis by Local Fitting , 1988 .

[7]  H. Sugiyama,et al.  The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001 , 2013, Radiation research.

[8]  D. Preston,et al.  Solid Cancer Incidence in the Techa River Incidence Cohort: 1956–2007 , 2015, Radiation research.

[9]  D L Preston,et al.  Studies of the mortality of A-bomb survivors. 8. Cancer mortality, 1950-1982. , 1987, Radiation research.

[10]  D A Pierce,et al.  Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. , 1996, Radiation research.

[11]  D. Preston,et al.  Radiation Effects on Mortality from Solid Cancers Other than Lung, Liver, and Bone Cancer in the Mayak Worker Cohort: 1948–2008 , 2015, PloS one.

[12]  H. Dohy,et al.  Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. , 1994, Radiation research.

[13]  R Doll,et al.  Mortality from cancer in relation to smoking: 50 years observations on British doctors , 2005, British Journal of Cancer.

[14]  S. Jablon,et al.  STUDIES OF THE MORTALITY OF A-BOMB SURVIVORS. 3. DESCRIPTION OF THE SAMPLE AND MORTALITY, 1950--1960. , 1965, Radiation research.

[15]  Division on Earth.  Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 , 2006 .

[16]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality. , 1994, Radiation research.

[17]  S. Jablon,et al.  AGREEMENT BETWEEN DEATH CERTIFICATE AND AUTOPSY DIAGNOSES AMONG ATOMIC BOMB SURVIVORS , 1994, Epidemiology.

[18]  Masahiro Ito,et al.  Long‐term trend of thyroid cancer risk among Japanese atomic‐bomb survivors: 60 years after exposure , 2013, International journal of cancer.

[19]  Charles Mw,et al.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. , 2003 .

[20]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. , 1994, Radiation research.

[21]  Yukiko Shimizu,et al.  Studies of the Mortality of Atomic Bomb Survivors.Report 12, Part I. Cancer: 1950–1990 , 2012, Radiation research.

[22]  D. L. Preston,et al.  Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998 , 2007, Radiation research.

[23]  D. Preston,et al.  Radiation and Smoking Effects on Lung Cancer Incidence among Atomic Bomb Survivors , 2010, Radiation research.

[24]  D O Stram,et al.  Allowing for dose-estimation errors for the A-bomb survivor data. , 1991, Journal of radiation research.

[25]  K. Kodama,et al.  DS02R1: Improvements to Atomic Bomb Survivors’ Input Data and Implementation of Dosimetry System 2002 (DS02) and Resulting Changes in Estimated Doses , 2017, Health physics.